<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83135">
  <stage>Registered</stage>
  <submitdate>5/09/2008</submitdate>
  <approvaldate>29/09/2008</approvaldate>
  <actrnumber>ACTRN12608000483358</actrnumber>
  <trial_identification>
    <studytitle>A three month randomised, prospective , single-blind controlled study to determine the effect of two dairy lipid preparations on bone and calcium metabolism in normal post-menopausal women.</studytitle>
    <scientifictitle>Effect of Dairy Lipids on Bone Metabolism in Normal Post-Menopausal Women</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Bone Metabolism</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Normal metabolism and endocrine development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>10 grams/day of one of two dairy lipid preparations containing stearic acid/12 weeks. Product A  has  15 % stearic acid as a percentage of all fatty acids and
product B has 10 % stearic acid as a percentage of all fatty acids.</interventions>
    <comparator>Normal diet/12 weeks</comparator>
    <control>Dose comparison</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Serum markers of bone turnover - Serum total alkaline phosphatase, osteocalcin, P1NP and C-telopeptide.</outcome>
      <timepoint>baseline, 2,4 8 and 12 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Urine markers of bone turnover - N-telopeptide and deoxypyridinoline</outcome>
      <timepoint>Baseline, 2, 4, 8 and 12 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Bone mineral density in lumbar spine, proximal femur and total body on Lunar Prodigy Densitometer</outcome>
      <timepoint>Baseline and 3 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy women at least 5 years post -menopause</inclusivecriteria>
    <inclusiveminage>45</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Osteoporosis (Bone Mineral Density(BMD) T score &lt;2.5 at hip or spine)
concurrent major systemic illness
renal impairment
chronic liver disease
active major gastrointestinal disease
metabolic bone diease
use of glucocorticoids in preceding 12 mths
use of bisphosphonates or Hormone Replacement Therapy (HRT) or other medications known to cause osteoporosis or interfere with bone metabolism.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Eligible .participants will be allocated to one of three groups, normal diet, or one of two preparations of dairy lipids. Allocation is concealed by the use of numbered containers.</concealment>
    <sequence>Randomisation will be undertaken using a variable block size schedule, based on computer generated random numbers.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Pharmacodynamics</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/10/2008</anticipatedstartdate>
    <actualstartdate>27/11/2008</actualstartdate>
    <anticipatedenddate>5/03/2009</anticipatedenddate>
    <actualenddate>5/03/2009</actualenddate>
    <samplesize>75</samplesize>
    <actualsamplesize>75</actualsamplesize>
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Lactopharma</primarysponsorname>
    <primarysponsoraddress>Private Bag 92032, Auckland, 1010.</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Lactopharma</fundingname>
      <fundingaddress>Private Bag 92032, Auckland,1010.</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This research study aims to find out whether new preparations of dairy lipids, like butters, have any effectson bone metabolism that might help revent osteoporosis.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern X Regional Ethics Committee</ethicname>
      <ethicaddress>Private Bag 92 522
Wellesley St
Auckland Central 1010</ethicaddress>
      <ethicapprovaldate>26/08/2008</ethicapprovaldate>
      <hrec>NTX/08/06/056</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Professor Ian Reid</name>
      <address>University of Auckland
Private Bag 92019
Auckland Mail Centre
Auckland 1142</address>
      <phone>64 9 3737599 ext 86259</phone>
      <fax />
      <email>i.reid@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Anne Horne</name>
      <address>University of Auckland
Private Bag 92019
Auckland Mail Centre
Auckland 1142</address>
      <phone>64 9 9239787</phone>
      <fax>64 9 3072865</fax>
      <email>a.horne@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Anne Horne</name>
      <address>University of Auckland
Private Bag 92019
Auckland Mail Centre
Auckland 1142.</address>
      <phone>9239787</phone>
      <fax>3072865</fax>
      <email>a.horne@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Ian Reid</name>
      <address>University of Auckland, Private Bag 92019, Auckland Mail Centre, Auckland, 1142</address>
      <phone>+64 9 9236259</phone>
      <fax />
      <email>i.reid@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>